Found: 11
Select item for more details and to access through your institution.
Relevance of admission hyperglycaemia and diabetes mellitus to efficacy and safety of mechanical thrombectomy in stroke patients.
- Published in:
- Polish Journal of Neurology & Neurosurgery / Neurologia i Neurochirurgia Polska, 2022, v. 56, n. 6, p. 472, doi. 10.5603/PJNNS.a2022.0063
- By:
- Publication type:
- Article
Characteristics of Giant Nodular Melanomas in Special Locations: a Case Series and Review of the Literature.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 12, p. 2851, doi. 10.1007/s13555-022-00841-8
- By:
- Publication type:
- Article
The Association of SNPs Located in the CDKN2B-AS1 and LPA Genes With Carotid Artery Stenosis and Atherogenic Stroke.
- Published in:
- Frontiers in Neurology, 2019, v. 10, p. 1, doi. 10.3389/fneur.2019.01170
- By:
- Publication type:
- Article
NGS Analysis of Liquid Biopsy (LB) and Formalin-Fixed Paraffin-Embedded (FFPE) Melanoma Samples Using Oncomine™ Pan-Cancer Cell-Free Assay.
- Published in:
- Genes, 2021, v. 12, n. 7, p. 1080, doi. 10.3390/genes12071080
- By:
- Publication type:
- Article
ASSOCIATION OF BREAST CANCER GRADE WITH RESPONSE TO NEOADJUVANT CHEMOTHERAPY ASSESSED POSTOPERATIVELY.
- Published in:
- Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists, 2019, v. 70, n. 2, p. 91, doi. 10.5114/pjp.2019.87101
- By:
- Publication type:
- Article
Plasma Levels of Occludin and Claudin-5 in Acute Stroke Are Correlated with the Type and Location of Stroke but Not with the Neurological State of Patients—Preliminary Data.
- Published in:
- Brain Sciences (2076-3425), 2020, v. 10, n. 11, p. 831, doi. 10.3390/brainsci10110831
- By:
- Publication type:
- Article
Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4384, doi. 10.3390/cancers15174384
- By:
- Publication type:
- Article
Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092123
- By:
- Publication type:
- Article
Long-Term Outcomes of Targeted Therapy after First-Line Immunotherapy in BRAF-Mutated Advanced Cutaneous Melanoma Patients—Real-World Evidence.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 8, p. 2239, doi. 10.3390/jcm11082239
- By:
- Publication type:
- Article
Clinical and Non-Clinical Determinants of the Effect of Mechanical Thrombectomy and Post-Stroke Functional Status of Patients in Short and Long-Term Follow-Up.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 21, p. 5084, doi. 10.3390/jcm10215084
- By:
- Publication type:
- Article
Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma.
- Published in:
- Targeted Oncology, 2023, v. 18, n. 2, p. 235, doi. 10.1007/s11523-023-00954-w
- By:
- Publication type:
- Article